Upgrade to SI Premium - Free Trial

Strategy (MSTR) PT Lowered to $350 at Bernstein SocGen Group

August 26, 2026 3:33 AM
Bernstein SocGen Group analyst Gautam Chhugani lowered the price target on Strategy (NASDAQ: MSTR) to $350.00 (from $450.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change